Literature DB >> 30306249

Crosstalk in transition: the translocation of Akt.

Catheryn W Gray1, Adelle C F Coster2.   

Abstract

Akt/PKB is an important crosstalk node at the junction between a number of major signalling pathways in the mammalian cell. As a significant nutrient sensor, Akt plays a central role in many cellular processes, including cell growth, cell survival and glucose metabolism. The dysregulation of Akt signalling is implicated in the development of many diseases, from diabetes to cancer. The translocation of Akt from cytosol to plasma membrane is a crucial step in Akt activation. Akt is initially synthesized on the endoplasmic reticulum, but translocates to the plasma membrane (PM) in response to insulin stimulation, where it may be activated. The Akt is then recycled to the cytoplasm. The activated Akt may propagate signals to downstream substrates both at the PM and in the cytosol, hence understanding the translocation dynamics is an important step in dissecting the signalling system. At the present time, however, knowledge concerning the translocation of either activated and unactivated Akt is scant. Here we present a simple, deterministic, three-compartment ordinary differential equation model of Akt translocation in vitro. This model can reproduce the salient features of Akt translocation in a manner consistent with the experimental data. Furthermore, we demonstrate that this system is equivalent to a damped harmonic oscillator, and analyse the steady state and transient behaviour of the model over the entire parameter space.

Entities:  

Keywords:  Akt/PKB; Insulin signaling; ODE model; Signalling

Mesh:

Substances:

Year:  2018        PMID: 30306249     DOI: 10.1007/s00285-018-1297-8

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  47 in total

1.  Kinetic analysis of platelet-derived growth factor receptor/phosphoinositide 3-kinase/Akt signaling in fibroblasts.

Authors:  Chang Shin Park; Ian C Schneider; Jason M Haugh
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

2.  A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.

Authors:  Mariko Hatakeyama; Shuhei Kimura; Takashi Naka; Takuji Kawasaki; Noriko Yumoto; Mio Ichikawa; Jae-Hoon Kim; Kazuki Saito; Mihoro Saeki; Mikako Shirouzu; Shigeyuki Yokoyama; Akihiko Konagaya
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

Review 3.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

Review 4.  Signaling specificity in the Akt pathway in biology and disease.

Authors:  Alex Toker; Sandra Marmiroli
Journal:  Adv Biol Regul       Date:  2014-04-19

5.  mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes.

Authors:  Richard C Hresko; Mike Mueckler
Journal:  J Biol Chem       Date:  2005-10-11       Impact factor: 5.157

6.  Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling.

Authors:  Eva Gonzalez; Timothy E McGraw
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

7.  Rapid activation of Akt2 is sufficient to stimulate GLUT4 translocation in 3T3-L1 adipocytes.

Authors:  Yvonne Ng; Georg Ramm; Jamie A Lopez; David E James
Journal:  Cell Metab       Date:  2008-04       Impact factor: 27.287

Review 8.  Akt signalling in health and disease.

Authors:  Ingeborg Hers; Emma E Vincent; Jeremy M Tavaré
Journal:  Cell Signal       Date:  2011-05-17       Impact factor: 4.315

9.  Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes.

Authors:  Shi-Xiong Tan; Yvonne Ng; Christopher C Meoli; Ansu Kumar; Poh-Sim Khoo; Daniel J Fazakerley; Jagath R Junutula; Shireen Vali; David E James; Jacqueline Stöckli
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

10.  Heterogeneous kinetics of AKT signaling in individual cells are accounted for by variable protein concentration.

Authors:  René Meyer; Lorenza A D'Alessandro; Sandip Kar; Bernhard Kramer; Bin She; Daniel Kaschek; Bettina Hahn; David Wrangborg; Johan Karlsson; Mats Kvarnström; Mats Jirstrand; Wolf-Dieter Lehmann; Jens Timmer; Thomas Höfer; Ursula Klingmüller
Journal:  Front Physiol       Date:  2012-11-28       Impact factor: 4.566

View more
  3 in total

Review 1.  Targeting AKT for cancer therapy.

Authors:  Maryam Shariati; Funda Meric-Bernstam
Journal:  Expert Opin Investig Drugs       Date:  2019-10-12       Impact factor: 6.206

2.  Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas.

Authors:  Xu Wang; Zhaohao Wang; Yu Zhang; Yan Wang; Hao Zhang; Shao Xie; Peng Xie; Rutong Yu; Xiuping Zhou
Journal:  Cell Prolif       Date:  2019-05-16       Impact factor: 6.831

3.  MiR-146a-5p targeting SMAD4 and TRAF6 inhibits adipogenensis through TGF-β and AKT/mTORC1 signal pathways in porcine intramuscular preadipocytes.

Authors:  Que Zhang; Rui Cai; Guorong Tang; Wanrong Zhang; Weijun Pang
Journal:  J Anim Sci Biotechnol       Date:  2021-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.